Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage company developing product candidates that treat neurodegenerative disorders, (the "Company” or "Cognition”), today reported financial ...

The trophy is the tangible reward. The intangibles could ripple further, especially on the Premier League title race.

Advancing zervimesine clinical development in DLB psychosis - - Meeting with FDA Division of Psychiatry expected by mid-2026 -- Management conference call at 8:30 a.m. ET today - PURCHASE, N.Y., March ...

Here's all you need to know about the ARS vs MCI, Carabao Cup 2026 final including preview, head-to-head, live streaming ...

Democrat Emily Gregory is hoping to score an upset for a seat in the Florida state House representing President Donald Trump.

This week Dr Ray O’Connor takes a look at the potential role of medication and vaccination on the prevention of dementia and ...

The Hong Kong University of Science and Technology (HKUST) today launched the NeuroCare Community Project (the Project), a five-year initiative to ...

Warangal invited application forms through online for the eligible candidates for admission into Masters in Public Health ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...

Pooled analyses in patients with moderate Alzheimer’s show dose-related cognitive benefit and signs of durability.100% of patients remained ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts ...

Real-World LEQEMBI Data Shows Patients Choose to Stay on Long-Term Treatment TOKYO and CAMBRIDGE, Mass., Mar 23, 2026 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that new ...